The mucolytic drug Mistabron is often used in bleeding situations. The purpose of this study is to assess the safety of this drug in such circumstances. The platelet function of human blood is not impaired by clinically used Mistabron dosage, after stimulation with epinephrine, ADP or arachidonic acid. Coagulation proteins are not modified by Mesna, neither in vitro (bloodfrom human beings), nor in vivo (rats).
Get full access to this article
View all access options for this article.
References
1.
DunklH (1976) Personal Communication, Feldkirch, Austria.
2.
KalendaZ (1974) 4th Europ. Congress Anesthesiology, Madrid, Sep. 5–11.
